Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 24, 2025 08:30 ET | Source: Er-Kim Pharmaceuticals

Er-Kim Enters Commercialization Agreement with Sentynl Therapeutics for Nulibry® (fosdenopterin) and Zokinvy® (lonafarnib), Targeting Ultra-Rare Diseases

Distribution agreement expands access of Nulibry and Zokinvy to 33 countries within CEE, the Mediterranean, and Eurasia
August 26, 2025 05:00 ET | Source: Er-Kim Pharmaceuticals

Er-Kim Announces Exclusive Agreement with CNX Therapeutics to Distribute Oncology Products Across CEE and Turkey

Er-Kim signs distribution agreement with CNX Therapeutics to distribute its portfolio of oncology medications across CEE and Turkey.
June 30, 2025 08:00 ET | Source: Er-Kim Pharmaceuticals

Er-Kim Announces Exclusive Agreement with Immunocore to Distribute KIMMTRAK in Turkey, and the MENA, Caucasus and CIS Regions

Er-Kim has partnered with Immunocore to bring KIMMTRAK (tebentafusp) to patients in Turkey, MENA, Caucasus, and CIS regions
January 14, 2025 08:00 ET | Source: Er-Kim

Er-Kim Announces Exclusive Distribution Agreement with the MEDICE Health Family For Vafseo® in Central & Eastern Europe

Er-Kim's partnership will support access of an alternative treatment to improve the lives of people impacted by anemia caused by chronic kidney disease